Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells
Journal of Controlled Release · 2023-09 · 361 · 455-469
DOI: 10.1016/j.jconrel.2023.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-09. Verfasst von Stefania Douka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, …. Hauptthemen laut MEDLINE: Nanoparticles, Neoplasms. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Natural killer (NK) cells participate in the immune system by eliminating cancer and virally infected cells through germline-encoded surface receptors. Their independence from prior activation as well as their significantly lower toxicity have placed them in the spotlight as an alternative to T cells for adoptive cell therapy (ACT). Engineering NK cells with mRNA has shown great potential in ACT by enhancing their tumor targeting and cytotoxicity. However, mRNA transfection of NK cells is challenging, as the most common delivery methods, such as electroporation, show limitations. Therefore, an alternative non-viral delivery system that enables high mRNA transfection efficiency with preservation of the cell viability would be beneficial for the development of NK cell therapies. In this study, we investigated both polymeric and lipid nanoparticle (LNP) formulations for eGFP-mRNA delivery to NK cells, based on a dimethylethanolamine and diethylethanolamine polymeric library and on different ionizable lipids, respectively. The mRNA nanoparticles based on cationic polymers showed limited internalization by NK cells and low transfection efficiency. On the other hand, mRNA-LNP formulations were optimized by tailoring the lipid composition and the microfluidic parameters, resulting in a high transfection efficiency (∼100%) and high protein expression in NK cells. In conclusion, compared to polyplexes and electroporation, the optimized LNPs show a greater transfection efficiency and higher overall eGFP expression, when tested in NK (KHYG-1) and T (Jurkat) cell lines, and cord blood-derived NK cells. Thus, LNP-based mRNA delivery represents a promising strategy to further develop novel NK cell therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands.
- Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands; School of Pharmacy, Drug Delivery Division,…
- Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands; Department of Biophysics, Paulista School of…
- Glycostem Therapeutics B.V., Kloosterstraat 9, 5349 AB Oss, the Netherlands.
- Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands. Electronic address: e.mastrobattista@uu.nl.
- Pharmaceutics division, Utrecht Institute for Pharmaceutical Sciences (UIPS), Faculty of Science, Utrecht University, Universiteitsweg 99, 3584, CG, Utrecht, the Netherlands; Department of Molecular Medicine and Medical…
Zitieren
APA
Douka, S., Brandenburg, L. E., Casadidio, C., Walther, J., Garcia, B. B. M., Spanholtz, J., Raimo, M., Hennink, W. E., Mastrobattista, E., & Caiazzo, M. (2023). Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells. Journal of Controlled Release, 361, 455-469. https://doi.org/10.1016/j.jconrel.2023.08.014
Vancouver
Douka S, Brandenburg LE, Casadidio C, Walther J, Garcia BBM, Spanholtz J, et al. Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells. Journal of Controlled Release. 2023;361:455-469. doi:10.1016/j.jconrel.2023.08.014
BibTeX
@article{Douka2023,
author = {Douka, Stefania and Brandenburg, Lisa E and Casadidio, Cristina and Walther, Johanna and Garcia, Bianca Bonetto Moreno and Spanholtz, Jan and Raimo, Monica and Hennink, Wim E and Mastrobattista, Enrico and Caiazzo, Massimiliano},
title = {Lipid nanoparticle-mediated messenger RNA delivery for ex vivo engineering of natural killer cells},
journal = {Journal of Controlled Release},
year = {2023},
volume = {361},
pages = {455--469},
doi = {10.1016/j.jconrel.2023.08.014}
}
EUVIMED